These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10376918)

  • 1. Muscarinic receptor stimulation with edrophonium hydrochloride does not elevate ventricular fibrillation thresholds in humans.
    Mitrani RD; Kloosterman EM; Huikuri H; Dylewski J; Atapattu S; Interian A; Castellanos A; Myerburg RJ
    J Cardiovasc Electrophysiol; 1999 Jun; 10(6):809-16. PubMed ID: 10376918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of ventricular vulnerable period and ventricular fibrillation threshold by use of T-wave shocks in patients undergoing implantation of cardioverter/defibrillators.
    Hou CJ; Chang-Sing P; Flynn E; Martinez L; Peterson J; Ottoboni LK; Liem LB; Sung RJ
    Circulation; 1995 Nov; 92(9):2558-64. PubMed ID: 7586357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenylephrine increases T wave shock energy required to induce ventricular fibrillation.
    Mitrani RD; Miles WM; Klein LS; Zipes DP
    J Cardiovasc Electrophysiol; 1998 Jan; 9(1):34-40. PubMed ID: 9475575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of low-energy T wave shocks for induction of ventricular fibrillation in patients with implantable cardioverter defibrillators.
    Bhandari AK; Isber N; Estioko M; Ziccardi T; Cannom DS; Park Y; Lerman RD; Prejean C; Sun GW
    J Electrocardiol; 1998 Jan; 31(1):31-7. PubMed ID: 9533375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The zone of vulnerability to T wave shocks in humans.
    Swerdlow CD; Martin DJ; Kass RM; Davie S; Mandel WJ; Gang ES; Chen PS
    J Cardiovasc Electrophysiol; 1997 Feb; 8(2):145-54. PubMed ID: 9147699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of induction method on defibrillation threshold and ventricular fibrillation cycle length.
    Zima E; Gergely M; Soós P; Gellér LA; Nemes A; Acsády G; Merkely B
    J Cardiovasc Electrophysiol; 2006 Apr; 17(4):377-81. PubMed ID: 16643358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shock on T versus direct current voltage for induction of ventricular fibrillation: a randomized prospective comparison.
    Sharma AD; Fain E; O'Neill PG; Skadsen A; Damle R; Baker J; Chauhan V; Mazuz M; Ross T; Zhang Z
    Pacing Clin Electrophysiol; 2004 Jan; 27(1):89-94. PubMed ID: 14720161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of the enhancement of vagal tone in acute myocardial infarction by edrophonium hydrochloride: effects on ventricular arrhythmias, His bundle electrography, and left ventricular function.
    Miller RR; Olson HG; Vera Z; DeMaria AN; Amsterdam EA; Mason DT
    Am Heart J; 1977 Feb; 93(2):222-8. PubMed ID: 835466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcutaneous T wave shock: a universal method for ventricular fibrillation induction.
    Mazer CD; Greene MB; Misale PS; Newman D; Dorian P
    Pacing Clin Electrophysiol; 1997 Dec; 20(12 Pt 1):2930-5. PubMed ID: 9455753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of ventricular fibrillation by T wave shocks: observations from monophasic action potential recordings.
    Shepard RK; Wood MA; Dan D; Clemo HF; Gilligan DM; Ellenbogen KA
    J Interv Card Electrophysiol; 1999 Dec; 3(4):335-40. PubMed ID: 10525249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shock-induced dispersion of ventricular repolarization: implications for the induction of ventricular fibrillation and the upper limit of vulnerability.
    Behrens S; Li C; Fabritz CL; Kirchhof PF; Franz MR
    J Cardiovasc Electrophysiol; 1997 Sep; 8(9):998-1008. PubMed ID: 9300297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of sotalol on ventricular fibrillation and defibrillation in humans.
    Dorian P; Newman D
    Am J Cardiol; 1993 Aug; 72(4):72A-79A. PubMed ID: 8346730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of ventricular fibrillation versus monomorphic ventricular tachycardia during programmed stimulation. Role of premature beat conduction delay.
    Avitall B; McKinnie J; Jazayeri M; Akhtar M; Anderson AJ; Tchou P
    Circulation; 1992 Apr; 85(4):1271-8. PubMed ID: 1372847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of ventricular fibrillation duration and site of initiation on the defibrillation threshold during early ventricular fibrillation.
    Strobel JS; Kenknight BH; Rollins DL; Smith WM; Ideker RE
    J Am Coll Cardiol; 1998 Aug; 32(2):521-7. PubMed ID: 9708486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of the defibrillation threshold using the upper limit of vulnerability following defibrillator implantation.
    Kirilmaz A; Dokumaci B; Uzun M; Kilicaslan F; Dinckal MH; Yucel O; Karaca M
    Pacing Clin Electrophysiol; 2005 Jun; 28(6):498-505. PubMed ID: 15955181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High dispersion of ventricular repolarization after an implantable defibrillator shock predicts induction of ventricular fibrillation as well as unsuccessful defibrillation.
    Moubarak JB; Karasik PE; Fletcher RD; Franz MR
    J Am Coll Cardiol; 2000 Feb; 35(2):422-7. PubMed ID: 10676690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of ventricular fibrillation based on monophasic action potential morphology in the human heart.
    Swartz JF; Jones JL; Fletcher RD
    Circulation; 1993 Jun; 87(6):1907-14. PubMed ID: 8504503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mean ventricular fibrillation cycle length: a potentially useful parameter for programming implantable cardioverter defibrillators.
    Li H; Easley A; Windle J; Samoil D; Barrington W
    Pacing Clin Electrophysiol; 1998 Sep; 21(9):1789-94. PubMed ID: 9744444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-peak to T-end interval for prediction of ventricular tachyarrhythmia and mortality in a primary prevention population with systolic cardiomyopathy.
    Rosenthal TM; Stahls PF; Abi Samra FM; Bernard ML; Khatib S; Polin GM; Xue JQ; Morin DP
    Heart Rhythm; 2015 Aug; 12(8):1789-97. PubMed ID: 25998895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exaggerated Reactivity of Parasympathetic Nerves Is Involved in Ventricular Fibrillation in J-Wave Syndrome.
    Shinohara T; Kondo H; Otsubo T; Fukui A; Yufu K; Nakagawa M; Takahashi N
    J Cardiovasc Electrophysiol; 2017 Mar; 28(3):321-326. PubMed ID: 27885745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.